Minerva Neurosciences(NERV)- NASDAQ
Company Description
Minerva Neurosciences, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. The company's product portfolio includes MIN-101, MIN-117, MIN-202 and... More
Sector: Healthcare
Industry: Biotechnology
Country: United States